Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950134-05-005079
Filing Date
2005-03-15
Accepted
2005-03-15 16:23:42
Documents
5
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d23382e10vk.htm 10-K 808247
2 LIST OF SUBSIDIARIES OF INTROGEN d23382exv21w1.htm EX-21.1 1992
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM d23382exv23w1.htm EX-23.1 1277
4 CERTIFICATION OF CEO AND CFO d23382exv31w1.htm EX-31.1 15090
5 CERTIFICATION OF CEO AND CFO PURSUANT TO SECTION 906 d23382exv32w1.htm EX-32.1 4932
  Complete submission text file 0000950134-05-005079.txt   833631
Mailing Address 301 CONGRESS AVE SUITE 1850 AUSTIN TX 78701
Business Address 301 CONGRESS AVE SUITE 1850 AUSTIN TX 78701 5127089310
INTROGEN THERAPEUTICS INC (Filer) CIK: 0001018710 (see all company filings)

EIN.: 742704230 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21291 | Film No.: 05681988
SIC: 2834 Pharmaceutical Preparations